Keeping you up to dateLatest Clearstate Healthcare Insights postsClearstate Insights is your single source to all our latest healthcare intelligence. From recently published reports offering thought-provoking analysis, to information about new products and services, we will ensure you are always kept informed. Sign up to Clearstate’s newsletter
Infectious disease IVD testing: Where APAC countries are putting their attention Economist Intelligence Clearstate expects strong growth for… In-vitro diagnostics | Asia | IVD Gateway
Digital pathology growth to outpace broader TDx market in several countries Laboratories that adopt digital pathology, support the… In-vitro diagnostics | Tissue Diagnostics (TDx) | IVD Gateway | Tissue Diagnostics (TDx)
Cancer and tissue diagnostics market outlook Tissue diagnostics (TDx) play an important role in improving… Cancer diagnostics | In-vitro diagnostics | Tissue Diagnostics (TDx) | Americas | Asia | Europe | IVD Gateway | Tissue Diagnostics (TDx)
Keeping ahead of infectious diseases in Asia-Pacific with increased testing Our new briefing paper looks at the testing trends in… Covid-19 testing | In-vitro diagnostics | Infectious Diseases Testing Monitor | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Asia | IVD Gateway | Molecular Diagnostics (MDx) | Next Generation Sequencing (NGS) | Point-of-care testing (POCT)
Rise of connected blood glucose testing at Chinese hospitals In China, the use of connected point-of-care blood glucose… In-vitro diagnostics | Point-of-care testing (POCT) | Asia | IVD Gateway | Point-of-care testing (POCT)
The future of point-of-care testing in Latin America (LATAM) Download our latest report on the future of point-of-care… In-vitro diagnostics | Point-of-care testing (POCT) | Americas | IVD Gateway | Point-of-care testing (POCT)
Future of Pathology: Four Growth Areas in Tissue Diagnostics Various technologies and advancements in tissue diagnostics… In-vitro diagnostics | Tissue Diagnostics (TDx) | Global | IVD Gateway | Tissue Diagnostics (TDx)
Covid-19: Three purchasing behaviour trends at molecular labs (Asia-Pacific) Download our latest IVD infographic "Covid-19: Three… In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | IVD Gateway
[On-demand Webinar] Covid-19 Impact: Molecular Diagnostic (MDx) Market EIU Healthcare zooms in on two of the fastest-growing… Covid-19 testing | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | Europe | Global | IVD Gateway | Molecular Diagnostics (MDx)
Key performance metrics fall in APAC top hospitals Key performance metrics around patient, bed utilisation and… General surgery | In-vitro diagnostics | Surgical device | Asia | Surgical Gateway
[On-demand Webinar] Will Covid-19 Accelerate the Next Wave of Adoption of Next-Generation Sequencing (NGS) in Healthcare? EIU Healthcare hosted the “Will Covid-19 Accelerate the… Covid-19 testing | In-vitro diagnostics | Next Generation Sequencing (NGS) | Asia | IVD Gateway
Covid-19 Testing Monitor: More than Seven-fold Increase in Diagnostic Testing Volume in the US, Brazil and India EIU Healthcare has launched the Covid-19 Testing Monitor –… Covid-19 testing | In-vitro diagnostics | Americas | Asia | Europe | Global | IVD Gateway
Sign up to our free newsletterThe latest trends and insights into the IVD and Surgical sectors, from our specialists and analysts, delivered directly to your inbox. Sign up to Clearstate’s newsletter today. Sign up now